CYP2W1 and hepatocellular carcinoma: Interestingly, recent studies have documented the reactivation of CYP2W1 expression in different cancers of epithelial origin such as the colon, colorectal, adrenal gland, breast, and hepatocellular carcinoma, with prevalence rates ranging from 30% to 60% [9,10,11,12].